Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase NA 2Phase EARLY_PHASE1 1Phase 4 1Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Venous Thrombosis 1Respiration Disorders 1Pulmonary Embolism 1Neoplasms 1Neoplasm Metastasis 1Lung Neoplasms 1Lung Diseases 1Brain Neoplasms 1

Interventions

Zoledronic Acid 5Bevacizumab 3exemestane 2Therapeutics 2Standard of Care 2Pamidronate 2Oxaliplatin 2Misoprostol 2Magnetic Resonance Spectroscopy 2Letrozole 2Ibandronic Acid 2Fulvestrant 2Fluorouracil 2Cetuximab 2Capecitabine 2vandetanib 1palbociclib 1liposomal doxorubicin 1huaier 1eribulin 1enzalutamide 1darolutamide 1cabozantinib 1aldesleukin 1abemaciclib 1Vindesine 1Trastuzumab 1Sugars 1Stents 1Specimen Handling 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Neoplasm Metastasis × Fluorodeoxyglucose F18 × Clear all
NCT05054998 2024-05-01

Dual Time Point FDG PET/MRI Scan in Improving the Imaging Cancer Patients With Brain Metastases

M.D. Anderson Cancer Center

Phase 4 Completed
12 enrolled
CNS

Brain Neoplasms, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡